Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial

Introduction Psilocybin-assisted therapy may be a new treatment for major depressive disorder (MDD), with encouraging data from pilot trials. In this trial (short name: PsiDeR) we aimed to test the feasibility of a parallel-group, randomised, placebo-controlled design. The primary outcomes in this t...

Full description

Bibliographic Details

Published in:	BMJ Open
Main Authors:	Ben Carter, Allan Young, James Rucker, Catherine Bird, Gemma Knight, Hassan Jafari, Tim Mantingh, Nadav Liam Modlin, Frederick Reinholdt, Camilla Day
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-12-01
Online Access:	https://bmjopen.bmj.com/content/11/12/e056091.full